Add BrightSurf on Google Email

No increased risk of gynecological cancer with testosterone use after five years

A large-scale study published in eClinicalMedicine found that transmasculine and gender-diverse individuals who use testosterone for an average of five years do not have an increased risk of gynecological cancer. The research, which followed 1955 participants, suggests that hormone therapy may be safe for this group.

SourceAmsterdam University Medical Center·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateMay 12, 2025

Liver cancer survival rates reflect income disparities

A study published in The Lancet Regional Health – Europe found that patients with low household income were more likely to be diagnosed late and receive less effective treatment for liver cancer. This highlights the need for targeted screening in deprived areas to improve early diagnosis and survival rates.

SourceUniversity of Gothenburg·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateMay 5, 2025

Dr. Adithya Hari joins Pennington Biomedical as physician/nuclear oncologist, adds to center’s strategic expansion of cancer metabolism program

Pennington Biomedical welcomes Dr. Adithya Hari, MD, with expertise in nuclear oncology and translational science, strengthening cancer research and patient-centered innovation in Louisiana. He will establish a research program focused on nuclear medicine and dedicate time to direct patient care through a clinical partnership.

Building trust in artificial intelligence for healthcare: Lessons from clinical oncology

A new review advocates for building confidence in AI applications by implementing robust data governance frameworks, enhancing transparency, and involving stakeholders. The authors emphasize the importance of addressing ethical implications and ensuring equitable access to AI-driven innovations in clinical oncology.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalAI in Precision Oncology·TypeCommentary/editorial·DateApr 30, 2025

Drug combination reduces breast cancer risk and improves metabolic health in rats

A combination of bazedoxifene and conjugated estrogens reduces obesity-related changes in rats, including fat cell accumulation and insulin resistance. The treatment also increases beneficial gut microbes and improves metabolic health, making it a promising alternative to tamoxifen for women at high breast cancer risk.

SourceMichigan Medicine - University of Michigan·JournalJCI Insight·TypeExperimental study·DateApr 28, 2025

The effects of smoking, drinking and lack of exercise are felt by the age of 36, new research indicates

Research found that bad habits like smoking, heavy drinking, and lack of exercise can lead to declines in health as young as 36, with effects more pronounced over the long-term. The study tracked hundreds of people for 30 years and found that three unhealthy behaviors were linked to poorer mental and physical health.

SourceTaylor & Francis Group·JournalAnnals of Medicine·TypeMeta-analysis·DateApr 24, 2025

AACR: Advancements in combination therapies for liver and pancreatic cancers, organoid-based platform for personalized head and neck cancer treatment, liquid biopsies for cancer detection and more

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center are presenting new findings on combination therapies for liver and pancreatic cancers, including a new organoid model for personalized head and neck cancer treatment. Additionally, they are discussing the potential of liquid biopsies for cancer detection and monitoring.

Unhealthy metabolic profile sharply increases risk of breast cancer returning and subsequent death from breast cancer among those who have survived the disease

A new study published in The Journal of Internal Medicine found that having an unhealthy metabolic profile increases the risk of breast cancer recurrence by 69% and subsequent breast cancer mortality by 83% among survivors. This association was consistent across Europe, North America, and Asia.

SourceEuropean Association for the Study of Obesity·JournalJournal of Internal Medicine·DateApr 16, 2025

Healthy nutrition and physical lifestyle choices lower cancer mortality risk for survivors, new ACS study finds

A new American Cancer Society study reveals that adopting healthy lifestyles, as recommended by the organization's guidelines, can significantly lower cancer mortality risk among survivors. Researchers found that those who maintained a healthy lifestyle before and after diagnosis had a lower mortality risk compared to those with poor a...

SourceAmerican Cancer Society·JournalJNCI Journal of the National Cancer Institute·DateApr 3, 2025

Being physically active, even just a couple of days a week, may be key to better health

New research published in the Journal of the American Heart Association suggests that even sporadic physical activity can have lasting health benefits, making it easier for people to prioritize their well-being amid busy schedules. The study found that completing 150 minutes of moderate to vigorous physical activity per week, regardles...

SourceAmerican Heart Association·JournalJournal of the American Heart Association·DateApr 2, 2025

High-fat diet promote breast cancer metastasis in animal models

Researchers discovered that a high-fat diet activates mechanisms facilitating breast cancer metastasis by promoting platelet activation and fibronectin expression, creating a fertile breeding ground for tumor cells to take root. This study provides new insights into the relationship between obesity and breast cancer spread.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalNature Communications·TypeExperimental study·DateApr 2, 2025

Awareness grows of cancer risk from alcohol consumption, survey finds

A survey by the Annenberg Public Policy Center found that over half of Americans believe drinking alcohol increases their chances of developing cancer. The Surgeon General's advisory on alcohol and cancer risk also contributed to increased public awareness, with nearly 3 in 10 respondents saying they would be less likely to accept a dr...

Patient navigators improve colonoscopy rates after abnormal stool tests, study shows

A study found that patient navigators significantly improved one-year follow-up colonoscopy completion rates by 12% and reduced time to follow-up by 27 days. The researchers emphasize the importance of timely follow-up colonoscopies for patients with abnormal stool test results.

SourceUniversity of Arizona Health Sciences·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateMar 31, 2025

Low-dose apixiban comparable to full dose for preventing VTE recurrence in patients with cancer

A new study has found that a lower dose of the blood-thinning medication apixaban is as effective as the full dose in preventing recurring blood clots in patients with active cancer. Patients who received the lower dose experienced fewer bleeding complications and similar VTE recurrence rates compared to those on the standard dose.

SourceAmerican College of Cardiology·JournalNew England Journal of Medicine·DateMar 29, 2025

ECU study finds exercise could reduce breast cancer recurrence

A recent study by Edith Cowan University found that a combination of resistance exercise and aerobic exercise can significantly reduce pro-inflammatory biomarkers in women with non-metastatic breast cancer. The research suggests that moderate to high-intensity aerobic exercises twice weekly, combined with resistance training, may help ...

SourceEdith Cowan University·JournalJNCI Journal of the National Cancer Institute·TypeMeta-analysis·DateMar 27, 2025

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, University of Oklahoma study finds

Patients with hormone receptor-positive and HER2-negative breast cancers face a higher risk of death from the cancer if they wait more than 42 days after diagnosis to have surgery. Delayed surgery increases the patient's risk exponentially, with risks of death increasing by 21%, 79%, and 183% at 60, 90, and 120 days, respectively.

SourceUniversity of Oklahoma·JournalBreast Cancer Research·TypeData/statistical analysis·DateMar 24, 2025

Do lifetime body weight patterns affect kidney cancer risk?

New research suggests that maintaining a healthy weight throughout life and losing weight later in life may reduce the risk of kidney cancer. Higher BMI at various ages across adulthood was associated with increased risks of developing different types of kidney cancer, including renal cell carcinoma, papillary RCC, and chromophobe RCC.

SourceWiley·JournalCancer·DateMar 24, 2025

Weight loss protects – even when weight is regained

A Swedish study of over 1,300 participants found that losing a significant amount of weight still offers protection against health issues like cancer and cardiovascular disease, even if some weight is regained. However, regaining weight can increase the risk of microvascular disease and other health problems.

SourceUniversity of Gothenburg·JournalThe Lancet Regional Health - Europe·TypeObservational study·DateMar 21, 2025

Mayo Clinic researchers identify a measurable genetic mutation as a significant predictor of metastasis and survival in pancreatic cancer

Researchers found that detectable mutant KRAS circulating tumor DNA (ctDNA) indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma. The study suggests that ctDNA assays should be performed prior to treatment to have the highest yield.

SourceMayo Clinic·JournalAnnals of Surgical Oncology·DateMar 19, 2025

Blind to the burn: Misconceptions about skin cancer risk in the US

Researchers investigated skin cancer risk perceptions and sun-protective behaviors in US adults, finding associations between sociodemographic factors and sunburn risks. Higher education levels, Hispanic origin, and income groups were linked to lower sunburn risks, while married or partnered individuals had higher risks.

SourceFlorida Atlantic University·JournalAmerican Journal of Lifestyle Medicine·TypeSurvey·DateMar 12, 2025

Effort seeks to increase cancer-gene testing in primary care

Researchers assess two approaches to test patients' hereditary cancer risks in primary care clinics, finding the point-of-care approach increases completion rates while the direct patient engagement method boosts testing rates among those eligible. The study's goal is to develop ways to improve uptake and reduce barriers to testing.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateMar 7, 2025

Diabetes drug could help cancer patients make better recovery

A new study published in the European Journal of Preventive Cardiology found that a type of diabetes medication called SGLT2 inhibitors can significantly lower the risk of heart failure and hospital visits related to heart failure in cancer patients. The benefits were particularly promising for breast cancer patients receiving anthracy...

SourceUniversity of East Anglia·JournalEuropean Journal of Preventive Cardiology·TypeMeta-analysis·DateMar 5, 2025

Tattoos may be linked to an increased risk of cancer

Researchers from the University of Southern Denmark found that tattooed individuals are more frequently diagnosed with skin and lymphoma cancers compared to those without tattoos. The study suggests that chronic inflammation in the lymph nodes triggered by tattoo ink may lead to abnormal cell growth and an increased risk of cancer.

SourceUniversity of Southern Denmark Faculty of Health Sciences·JournalBMC Public Health·TypeData/statistical analysis·DateMar 3, 2025